Scientists from Australia will stop the upcoming death? The secret of venom of the spider
Researchers at the University of Queensland in north-eastern Australia report to discover an unusual chemical relationship in spider’s venom. They claim that he may be the key to selecting death in the bud.
A spider can be a breakthrough for the development of medicine, which lives on the sandy islands on the east coast of Australia and copies of tunnels, in which he sets spider paddles for his victims. This species reminiscent of a small taranty does not threaten people, but it has fangs with which he introduces venom to the organisms of small rodents.
Australian scientists want to stop death
Biochemist Glenn King from the University of Queensland became interested in this amazing toxin. He isolated a chemical compound in the spider’s venom, which can help create a drug that protects the tissue against destruction in the event of a heart attack or stroke. This solution can work if the patient receives the medicine during several hours. Experts already announce that this can completely change the picture of medicine.
During the stroke, man loses to 2 million neurons per minute, which leads to brain damage. The same happens in the case of a heart attack. In such cases, the blood does not flow to the organs, which causes a chain reaction, which in a simplified end ends with the activation of stress signals by the tissues, which require cells to death.
Will the spider venom help victims of strokes and heart attacks?
Scientists from Australia argue that the chemical compounds in the spider toxin are perfect for taking over these cell signals. Jad works in such a way that it turns off the victim’s nervous systems. King and an expert on heart disease Nathan Palpant found that a certain spider’s venom molecule blocks the signals that activate cell death. During tests on mice, they managed to reduce the destruction of mice in the brains of 80 percent. Even four hours after starting the stroke. They described their achievements in The Scientist.
Both researchers founded the Bioscience company based in Brisbane, which will now conduct clinical tests. Later this year, patients who are experiencing heart attacks will be attempted. If the tests turn out to be safe and effective, the new drug will be able to hit the hands of medics in the next five years.
